To evaluate the safety and feasibility of the new robotic TELELAP ALF-X platform in a heterogeneous series of gynecological procedures.
Between September 2013 and May 2014, 146 patients were enrolled in this Phase II study trial. Patients with presumed benign or borderline adnexal disease, and benign and early stage malignant uterine disease were prospectively included.
Median age was 52 years (range 19–79 years), and median BMI was 23.7 (range 17.3–34.0 kg/m2). Sixty-two patients (32.5 %) underwent mono/bilateral salpingo-oophorectomy or cyst removal (Group A), four patients (2.7 %) myomectomy (Group B), 46 patients (31.5 %) total hysterectomy (Group C), and 34 (23.3 %) endometrial cancer staging (Group D). Median docking time was 7 min (range 3–36). Median OT was 35 min (range 17–145) in the Group A, 40 min (range 10–50) in the Group B, 133 min (range 58–320) in the Group C, and 160 min (range 69–290) in the Group D. Reduction in OT over the study period for hysterectomy (p < 0.001) and adnexal surgery (p < 0.002) was observed. We registered two laparoscopic conversion (3.2 %) in the Group A and two (4.3 %) in the Group C. In the Group D, we showed one (2.9 %) laparoscopic and two (5.8 %) laparotomic conversions. One patient (2.17 %) in the Group C was readmitted in the early postoperative period for severe vaginal bleeding.
We report the first series of a novel robotic approach for the treatment of various gynecological conditions. When performed by experienced minimally invasive surgeons, TELELAP ALF-X is feasible and safe. Further studies are mandatory to define the benefits, advantages, and costs of this new robotic approach with respect to others minimally invasive approaches.
This is a preview of subscription content, access via your institution.
Buy single article
Instant access to the full article PDF.
Tax calculation will be finalised during checkout.
Nieboer TE, Johnson N, Lethaby A, Tavender E, Curr E, Garry R, van Voorst S, Mol BW, Kluivers KB (2009) Surgical approach to hysterectomy for benign gynaecological disease. Cochrane Database Syst Rev (3):CD003677
Fanfani F, Fagotti A, Ercoli A, Bifulco G, Longo R, Mancuso S, Scambia G (2004) A prospective randomized study of laparoscopy and minilaparotomy in the management of benign adnexal masses. Hum Reprod 19:2367–2371
Langerbrekke A, Istre O, Hallqvist AC, Hartgill TW, Onsrud M (2002) Comparison of laparoscopy and laparotomy in patients with endometrial cancer. J Am Assoc Gynecol Laparosc 9:152–157
Fader AN, Seamon LG, Escobar PF, Frasure HE, Havrilesky LA, Zanotti KM, Secord AA, Boggess JF, Cohn DE, Fowler JM, Skafianos G, Rossi E, Gehrig PA (2012) Minimally invasive surgery versus laparotomy in women with high grade endometrial cancer: a multi-site study performed at high volume cancer centers. Gynecol Oncol 126:180–185
Mori KM, Neubauer NL (2013) Minimally invasive surgery in gynecologic oncology. ISRN Obstet Gynecol 2013:312982
Fanfani F, Fagotti A, Rossitto C, Gagliardi ML, Ercoli A, Gallotta V, Gueli Alletti S, Monterossi G, Turco LC, Scambia G (2012) Laparoscopic, minilaparoscopic and single-port hysterectomy: perioperative outcomes. Surg Endosc 26:3592–3596
Ghezzi F, Cromi A, Siesto G, Uccella S, Boni L (2011) Minilaparoscopic versus conventional laparoscopic hysterectomy: results of randomized trial. J Minim Invasive Gynecol 18:455–456
Fanfani F, Fagotti A, Gagliardi ML, Monterossi G, Rossitto C, Costantini B, Gueli Alletti S, Vizzielli G, Ercoli A, Scambia G (2013) Minilaparoscopic versus single-port total hysterectomy: a randomized trial. J Minim Invasive Gynecol 20:192–197
Scheib SA, Fader AN (2015) Gynecologic robotic laparoendoscopic single-site surgery: prospective analysis of feasibility, safety, and technique. Am J Obstet Gynecol 212(2):179
Rosero EB, Kho KA, Joshi GP, Giesecke M, Schaffer JI (2013) Comparison of robotic and laparoscopic hysterectomy for benign gynecologic disease. Obstet Gynecol 122:778–786
Gidaro S, Altobelli E, Falavolti C, Bove AM, Ruiz EM, Stark M, Ravasio G, Lazzaretti SS, Maurizio B (2014) Vesicourethral anastomosis using a novel telesurgical system with haptic sensation, the Telelap Alf-X: a pilot study. Surg Technol Int 24:35–40
Lococo A, Larocca V, Marino F, De Filippis AF, Cesario A, Lococo F (2014) Experimental robotic pulmonary lobectomy with the TELELAP/ALFX system in the ovine model. Surg Innov. doi:10.1177/1553350614549633
Stark M, Benhidjeb T, Gidaro S, Morales ER (2012) The future of telesurgery: a universal system with haptic sensation. J Turk Ger Gynecol Assoc 13:74–76
Gidaro S, Buscarini M, Ruiz E, Stark M, Labruzzo A (2012) Telelap Alf-X: a novel telesurgical system for the 21st century. Surg Technol Int 22:20–25
Fagotti A, Bottoni C, Vizzielli G, Rossitto C, Tortorella L, Monterossi G, Fanfani F, Scambia G (2012) Laparoendoscopic single-site surgery (LESS) for treatment of benign adnexal disease: single-center experience over 3-years. J Minim Invasive Gynecol 19:695–700
Francesco Fanfani, Giorgia Monterossi, Anna Fagotti, Cristiano Rossitto, Salvatore Gueli Alletti, Barbara Costantini, Valerio Gallotta, Luigi Selvaggi, Stefano Restaino, and Giovanni Scambia have no conflict of interest or financial ties to disclose. The TELELAP ALF-X was offered by the SOFAR s.p.a. for the study period.
About this article
Cite this article
Fanfani, F., Monterossi, G., Fagotti, A. et al. The new robotic TELELAP ALF-X in gynecological surgery: single-center experience. Surg Endosc 30, 215–221 (2016). https://doi.org/10.1007/s00464-015-4187-9
- TELELAP ALF-X
- Robotic surgery
- Minimally invasive surgery